Table 2 PET/CT parameters of the entire cohort and comparison between patients with and without driveline infection in PET/CT.

From: Interplay between driveline infection, vessel wall inflammation, cerebrovascular events and mortality in patients with left ventricular assist device

Clinical characteristics

All patients

n = 118

Driveline infection at baseline PET/CT n = 92

No driveline infection at baseline PET/CT n = 26

p

Period between initial PET/CT and death in days

366 (125 – 743)

366 (147 – 752)

349 (101 – 653)

0.354

Average SUVmax thoracic vessels

2.9286 ± 0.4891

2.9544 ± 0.4875

2.7969 ± 0.5196

0.172

SUVmax subcutaneous driveline pathway

8.52 (5.62 – 12.92)

10.0167 ± 4.5796

6.5744 ± 4.2371

 < 0.001*

SUVmax driveline entry point

4.71 (2.64 – 8.415)

6.045 (3.575 – 9.698)

2.33 (1.9 – 3.095)

 < 0.001*

SUVmax outflow graft

6.245 (4.93 – 9.06)

6.43 (4.735 –

9.238)

5.91 (5.258 –

7.803)

0.548

SUVmax pump pocket

7.455 (5.245 – 10.37)

7.42 (5.17 – 10.64)

8 (6.155 – 9.78)

0.907

SUVmax sternum

6.86 (4.99 – 9.31)

7.23 (5.22 – 9.64)

5.92 (4.17 – 7.58)

0.041*

  1. Results are displayed as frequencies (percentages), metric data as mean ± SD if normally distributed or median with interquartile range (25–75th percentile) if not normally distributed. p < 0.05 is considered statistically significant; PET/CT  positron emission tomography/computed tomography, SUV  standardized uptake value, IQR Interquartile range. Significant values are in bold.